Akèy › Maladi poumon › Oklahoma
Etid klinik pou Maladi poumon nan Oklahoma
5 etid pou Maladi poumon ap chèche patisipan nan sit nan Oklahoma.
Vil nan Oklahoma
Tèks ofisyèl etid la (Anglè)
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- University of Oklahoma, Oklahoma City
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06128551A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- OK Clinical Research, Edmond
- Allergy, Asthma and Clinical Research, Oklahoma City
- Layrek Clinical Research, Tulsa
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Sep 22, 2026 · NCT06977581Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Oklahoma City
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT05624450A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
- Research Site, Oklahoma City
Ap rekriteFaz 2
Laj 4 a 11 · Tout sèks · Mizajou Aug 27, 2026 · NCT07525375Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- University of Oklahoma Health Sciences Center (OUHSC), Oklahoma City
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Nov 12, 2025 · NCT05975983Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.